Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 7/20 | 0.66 |
| ▸ | IMPDH1 | P20839 | 2/20 | 0.66 |
| ▸ | TGM2 | P21980 | 1/20 | 0.64 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.64 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.63 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.63 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.62 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.62 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.62 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.61 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.61 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.61 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.61 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.59 |
| ▸ | NT5E | P21589 | 2/20 | 0.59 |
| ▸ | KRAS | P01116 | 2/20 | 0.58 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.58 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18574074 | 0.99 | P2RX3 (0.65) | IMPDH2IMPDH1TGM2P2RX3TAS1R3 | |
| SCHEMBL30363045 | 0.99 | P2RX3 (0.65) | IMPDH2IMPDH1TGM2P2RX3TAS1R3 | |
| SCHEMBL14946399 | 0.99 | P2RX3 (0.65) | IMPDH2IMPDH1TGM2P2RX3TAS1R3 | |
| SCHEMBL14929515 | 0.99 | P2RX3 (0.65) | IMPDH2IMPDH1TGM2P2RX3TAS1R3 | |
| SCHEMBL263726 | 0.93 | IMPDH2 (0.75) | IMPDH2IMPDH1TGM2P2RX3TAS1R3 | |
| SCHEMBL14929355 | 0.89 | IMPDH2 (0.64) | IMPDH2IMPDH1TGM2P2RX3TAS1R3 | |
| SCHEMBL18574075 | 0.89 | IMPDH2 (0.64) | IMPDH2IMPDH1TGM2P2RX3TAS1R3 | |
| SCHEMBL14946391 | 0.89 | IMPDH2 (0.64) | IMPDH2IMPDH1TGM2P2RX3TAS1R3 | |
| SCHEMBL18269536 | 0.88 | P2RX3 (0.68) | IMPDH2IMPDH1TGM2P2RX3TAS1R3 | |
| SCHEMBL18289612 | 0.88 | P2RX3 (0.68) | IMPDH2IMPDH1TGM2P2RX3TAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9067964-B2 | Complex and method for enhancing nuclear delivery | OLIGOMER SCIENCES AB (SE) | 2015-06-30 | — | — | US | disclosed |
| US-20110306138-A1 | COMPLEX AND METHOD FOR ENHANCING NUCLEAR DELIVERY | OLIGOMER SCIENCES AB (SE) | 2011-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306138-A1 | COMPLEX AND METHOD FOR ENHANCING NUCLEAR DELIVERY | SNRPE, SNRPA, HNRNPH3 | IMPDH2 1756/4885IMPDH1 2006/4885TGM2 1855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.